Intuitive Surgical Inc. (ISRG) Rating Reiterated by Wedbush
Intuitive Surgical Inc. (NASDAQ:ISRG)‘s stock had its “outperform” rating reiterated by investment analysts at Wedbush in a research note issued on Wednesday. They currently have a $755.00 target price on the stock, down from their previous target price of $785.00. Wedbush’s price target would indicate a potential upside of 4.61% from the stock’s current price.
A number of other analysts have also issued reports on ISRG. Zacks Investment Research lowered Intuitive Surgical from a “hold” rating to a “sell” rating in a report on Tuesday, June 21st. Bank of America Corp. reaffirmed a “buy” rating on shares of Intuitive Surgical in a report on Wednesday, June 22nd. Stifel Nicolaus raised their target price on Intuitive Surgical from $700.00 to $800.00 and gave the company a “buy” rating in a report on Wednesday, July 20th. Canaccord Genuity raised their target price on Intuitive Surgical from $700.00 to $750.00 and gave the company a “buy” rating in a report on Wednesday, July 20th. Finally, BTIG Research reaffirmed a “neutral” rating on shares of Intuitive Surgical in a report on Wednesday, July 20th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and fourteen have given a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $710.82.
Shares of Intuitive Surgical (NASDAQ:ISRG) opened at 721.73 on Wednesday. Intuitive Surgical has a one year low of $483.11 and a one year high of $727.25. The stock has a 50 day moving average price of $703.09 and a 200-day moving average price of $666.36. The company has a market capitalization of $27.78 billion, a P/E ratio of 40.96 and a beta of 0.72.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/19/intuitive-surgical-inc-isrg-rating-reiterated-by-wedbush.html
Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 18th. The company reported $6.19 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $5.13 by $1.06. The firm had revenue of $682.90 million for the quarter, compared to analyst estimates of $650.49 million. Intuitive Surgical had a return on equity of 15.25% and a net margin of 26.80%. The company’s revenue was up 15.8% on a year-over-year basis. During the same quarter last year, the firm posted $5.24 EPS. Equities research analysts predict that Intuitive Surgical will post $21.30 earnings per share for the current fiscal year.
In other news, SVP Curet Myriam sold 4,250 shares of Intuitive Surgical stock in a transaction on Wednesday, July 27th. The stock was sold at an average price of $684.39, for a total value of $2,908,657.50. Following the completion of the sale, the senior vice president now directly owns 3,133 shares of the company’s stock, valued at approximately $2,144,193.87. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Marshall Mohr sold 5,000 shares of Intuitive Surgical stock in a transaction on Wednesday, July 27th. The shares were sold at an average price of $684.09, for a total value of $3,420,450.00. Following the completion of the sale, the chief financial officer now directly owns 6,725 shares of the company’s stock, valued at $4,600,505.25. The disclosure for this sale can be found here. Corporate insiders own 3.10% of the company’s stock.
Large investors have recently added to or reduced their stakes in the stock. Riverhead Capital Management LLC boosted its stake in Intuitive Surgical by 59.8% in the first quarter. Riverhead Capital Management LLC now owns 17,965 shares of the company’s stock valued at $10,798,000 after buying an additional 6,722 shares during the period. Marsico Capital Management LLC boosted its stake in Intuitive Surgical by 37.1% in the first quarter. Marsico Capital Management LLC now owns 22,879 shares of the company’s stock valued at $13,751,000 after buying an additional 6,196 shares during the period. AXA boosted its stake in Intuitive Surgical by 174.9% in the first quarter. AXA now owns 28,186 shares of the company’s stock valued at $16,941,000 after buying an additional 17,934 shares during the period. Pictet Asset Management Ltd. boosted its stake in Intuitive Surgical by 48.7% in the first quarter. Pictet Asset Management Ltd. now owns 70,535 shares of the company’s stock valued at $39,716,000 after buying an additional 23,087 shares during the period. Finally, Edmond DE Rothschild Holding S.A. purchased a new stake in Intuitive Surgical during the first quarter valued at approximately $619,000. 92.03% of the stock is owned by institutional investors.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.